ALANNA JORGENSEN: Open Payments
NPI 1538896337 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,572 in 131 payments from 20 companies in 2025. Trend: 2023 $1,041 · 2024 $1,994 · 2025 $2,572
Food & beverage: $2,572
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $541 |
| ABBVIE INC. | 29 | $458 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $292 |
| Madrigal Pharmaceuticals | 6 | $189 |
| Aimmune Therapeutics, Inc. | 6 | $148 |
| Ardelyx, Inc. | 8 | $136 |
| Celltrion USA Inc. | 5 | $133 |
| QOL Medical, LLC | 4 | $103 |
| Organon LLC | 5 | $94 |
| ORPHALAN INC | 3 | $87 |
Products named: TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, DUPIXENT, SKYRIZI, IBSRELA, VEGZELMA.
Industry payments across UT — which companies pay providers there.
